Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Testing the Long-Term Stability of Vancomycin Ophthalmic Solution

Author(s):  McLellan Christine, Ngo Van, Pasedis Sophia, Dohlman Claes H

Issue:  Sep/Oct 2008 - Veterinary Compounding
View All Articles in Issue

Page(s):  456-459

Testing the Long-Term Stability of Vancomycin Ophthalmic Solution Page 1
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution Page 2
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution Page 3
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution Page 4

Download in electronic PDF format for $75

Abstract:  Some patients with a keratoprosthesis (artificial cornea) are required to use prophylactic vancomycin ophthalmic solution daily for life to prevent infection, a regimen which has proven to be highly successful. The objective of this study was to determine whether such vancomycin solutions would remain stable at room temperature for an extended period of time, beyond that suggested by available published stability data and used in current practice. By relaxing the storage requirement and extending the expiration date of this solution, it was hoped that patient adherence and satisfaction would increase. The studied vancomycin ophthalmic solutions were compounded at the Massachusetts Eye and Ear Infirmary, Department of Pharmacy Services, Boston, Massachusetts, and were sent to an outside laboratory for high-performance liquid chromatography potency testing at predefined time points. Vancomycin 14-mg/mL ophthalmic solution compounded with 0.005% benzalkonium retains potency for at least 60 days at room temperatu

Related Keywords: Christine McLellan, PharmD, RPh, Van Ngo, BS, RPh, Sophia Pasedis, BS, PharmD, RPh, Claes H. Dohlman, MD, PhD, vancomycin, antimicrobial agent, antibiotic, eye disorders, ocular infection, corneal opacity, corneal transplant, keratoprosthesis, complications, blindness, prevention, prophylaxis, bacterial endophthalmitis, benzalkonium chloride, preservative, stability, potency

Related Categories: OPHTHALMICS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, INFECTIOUS DISEASE, PREVENTIVE MEDICINE/WELLNESS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution
McLellan Christine
, Ngo Van, Pasedis Sophia, Dohlman Claes H
Sep/Oct 2008
Pg. 456-459

Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes
Bartoll Aaron Puplà
, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
Jul/Aug 2022
Pg. 330-335

Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product
Huvelle Sophie
, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Jul/Aug 2016
Pg. 347-350

Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product
Huvelle Sophie
, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Sep/Oct 2016
Pg. 416-420

Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2010
Pg. 421

New Perspectives on Vancomycin Use in Home Care, Part 1
Kastango Eric S
, Hadaway Lynn
Nov/Dec 2001
Pg. 465-469

Vancomycin 31-mg/mL Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2011
Pg. 508

Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops
Sahyoun Jean-Yves
, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
Jul/Aug 2022
Pg. 336-341

Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation
Robert Marie-Claude
, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
Sep/Oct 2014
Pg. 418-426

Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2016
Pg. 56

Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups
Kirk Loren
, Lewis Paul, Luu Yao, Brown Stacy
Mar/Apr 2016
Pg. 159-163

Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin
Baker Daniel S
, Waldrop Bruce, Arnold John
Jul/Aug 2010
Pg. 346-349

Development and Validation of a Stability-indicating High-performance Liquid Chromatographic Method for Quantification of Progesterone in Compounded Glycerinated Gelatin Troches
Burrows Anna C
, Yellepeddi Venkata Kashyap, Snyder Spencer, Wakefield Meagan, Jackson David, Huynh Johnny, Nguyen Khoa, Sayre Casey L
Jul/Aug 2019
Pg. 340-350

Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
Nov/Dec 2016
Pg. 495-500

Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C
, Ben Michel, Trusley Craig, Trissel Lawrence A
Mar/Apr 2008
Pg. 170-173

Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula
Hossain Mohammad Faisal
, Levesque Dan, Frye John, Rashid Mamoon
Jul/Aug 2020
Pg. 322-326

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
Sep/Oct 2016
Pg. 399-404

Stability of Vancomycin HCl in MEDICATION CASSETTE Reservoirs
Allen Loyd V Jr
, Stiles M Lou
Mar/Apr 1997
Pg. 123-124

Return to Top